Ausgabe 4/2016
Inhalt (9 Artikel)
Acute Lymphocytic Leukemias (K Ballen, Section Editor)
Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia
Ajoy Dias, Saad J. Kenderian, Gustavo F. Westin, Mark R. Litzow
Health Economics (N Khera, Section Editor)
Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia
Manali I. Patel
Health Economics (N Khera, Section Editor)
Exploring Big Data in Hematological Malignancies: Challenges and Opportunities
Gustavo F. Westin, Ajoy L. Dias, Ronald S. Go
Health Economics (N Khera, Section Editor)
Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant
Anna Barata, William A. Wood, Sung Won Choi, Heather S. L. Jim
Health Economics (N Khera, Section Editor)
Oral Chemotherapy in Patients with Hematological Malignancies—Care Process, Pharmacoeconomic and Policy Implications
Jeffrey Betcher, Elizabeth Dow, Nandita Khera
Health Economics (N Khera, Section Editor)
Bending the Cost Curve in Childhood Cancer
Heidi Russell, M. Brooke Bernhardt
Health Economics (N Khera, Section Editor)
Value Based Care and Patient-Centered Care: Divergent or Complementary?
Eric K. Tseng, Lisa K. Hicks
CART and Immunotherapy (M Ruella, Section Editor)
T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies
Nasheed M. Hossain, Aude G. Chapuis, Roland B. Walter
CART and Immunotherapy (M Ruella, Section Editor)
Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies
Saar Gill